MimiVax, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (NCT05163080) | MimiVax, LLC | 2021-11-18 |
Track MimiVax, LLC automatically
Every clearance here is in the API, with alerts when new ones post.